PL373891A1 - Mycoplasma bovis vaccine and methods of reducing pneumonia in animals - Google Patents

Mycoplasma bovis vaccine and methods of reducing pneumonia in animals

Info

Publication number
PL373891A1
PL373891A1 PL02373891A PL37389102A PL373891A1 PL 373891 A1 PL373891 A1 PL 373891A1 PL 02373891 A PL02373891 A PL 02373891A PL 37389102 A PL37389102 A PL 37389102A PL 373891 A1 PL373891 A1 PL 373891A1
Authority
PL
Poland
Prior art keywords
animals
methods
mycoplasma bovis
bovis vaccine
pneumonia
Prior art date
Application number
PL02373891A
Other languages
English (en)
Polish (pl)
Inventor
Robin Lee Keich
David Ross Mcgavin
Robert John Yancey
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of PL373891A1 publication Critical patent/PL373891A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL02373891A 2001-07-02 2002-06-27 Mycoplasma bovis vaccine and methods of reducing pneumonia in animals PL373891A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30263801P 2001-07-02 2001-07-02

Publications (1)

Publication Number Publication Date
PL373891A1 true PL373891A1 (en) 2005-09-19

Family

ID=23168600

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02373891A PL373891A1 (en) 2001-07-02 2002-06-27 Mycoplasma bovis vaccine and methods of reducing pneumonia in animals

Country Status (31)

Country Link
US (1) US20030147914A1 (enExample)
EP (1) EP1401488A1 (enExample)
JP (1) JP2004536106A (enExample)
KR (1) KR20040030783A (enExample)
CN (1) CN1522152A (enExample)
AP (1) AP2002002568A0 (enExample)
AR (1) AR036125A1 (enExample)
BG (1) BG108496A (enExample)
BR (1) BR0210798A (enExample)
CA (1) CA2452580A1 (enExample)
CZ (1) CZ20033465A3 (enExample)
EA (1) EA200301324A1 (enExample)
GT (1) GT200200139A (enExample)
HN (1) HN2002000162A (enExample)
HR (1) HRP20031078A2 (enExample)
HU (1) HUP0501188A2 (enExample)
IL (1) IL159516A0 (enExample)
IS (1) IS7078A (enExample)
MA (1) MA27048A1 (enExample)
MX (1) MXPA03011815A (enExample)
NO (1) NO20035767L (enExample)
OA (1) OA12640A (enExample)
PA (1) PA8549801A1 (enExample)
PE (1) PE20030239A1 (enExample)
PL (1) PL373891A1 (enExample)
SK (1) SK15802003A3 (enExample)
TN (1) TNSN03154A1 (enExample)
UY (1) UY27365A1 (enExample)
WO (1) WO2003004052A1 (enExample)
YU (1) YU102103A (enExample)
ZA (1) ZA200309747B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
WO2008030619A2 (en) * 2006-09-07 2008-03-13 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
MX2009001849A (es) 2006-09-11 2009-03-02 Pfizer Prod Inc Bacterinas tratadas con calor, y vacunas de emulsion preparadas a partir de estas bacterinas tratadas con calor.
CL2008003202A1 (es) * 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
NZ589981A (en) * 2008-07-03 2012-11-30 Univ Iowa State Res Found Inc Cattle vaccines comprising a disrupted M. bovis bacterium
AU2009309041B2 (en) * 2008-10-31 2016-02-04 Boehringer Ingelheim Animal Health USA Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
KR20170077255A (ko) 2009-06-04 2017-07-05 고쿠리츠칸센쇼켄쿠죠 마이코플라즈마 감염증용 백신
CN102220263B (zh) * 2011-05-06 2012-10-03 华中农业大学 一种牛支原体致弱菌株及其应用
UA121193C2 (uk) 2012-12-28 2020-04-27 Бьорінгер Інгельхайм Ветмедіка Гмбх Спосіб одержання імуногенної композиції проти мікоплазми
CN104857509A (zh) * 2015-06-02 2015-08-26 福清市默克兽医院 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法
CN108135989B (zh) 2015-08-14 2022-08-09 硕腾服务有限责任公司 牛支原体组合物
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
CN106929452B (zh) * 2017-04-11 2020-06-12 河南省农业科学院畜牧兽医研究所 一株牛支原体及其应用
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN112301041B (zh) * 2020-10-09 2022-05-24 华中农业大学 牛支原体p21蛋白及其应用
CN113546162B (zh) * 2021-05-31 2023-07-18 江苏省农业科学院 一种支原体疫苗及其制备方法
CN113604492B (zh) * 2021-09-10 2023-07-07 苏州世诺生物技术有限公司 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
CA2390613A1 (en) * 1999-11-08 2001-05-17 Biomune Vaccines for mycoplasma bovis and methods of use
DE29921392U1 (de) * 1999-12-06 2000-03-16 Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
TNSN03154A1 (fr) 2005-12-23
HN2002000162A (es) 2002-09-17
HRP20031078A2 (en) 2005-08-31
MXPA03011815A (es) 2004-04-02
SK15802003A3 (sk) 2005-01-03
PE20030239A1 (es) 2003-03-21
KR20040030783A (ko) 2004-04-09
WO2003004052A1 (en) 2003-01-16
BG108496A (en) 2005-02-28
IL159516A0 (en) 2004-06-01
JP2004536106A (ja) 2004-12-02
AR036125A1 (es) 2004-08-11
EA200301324A1 (ru) 2004-12-30
EP1401488A1 (en) 2004-03-31
HUP0501188A2 (en) 2006-05-29
NO20035767L (no) 2004-01-30
IS7078A (is) 2003-12-15
CA2452580A1 (en) 2003-01-16
BR0210798A (pt) 2006-05-23
US20030147914A1 (en) 2003-08-07
PA8549801A1 (es) 2003-09-17
MA27048A1 (fr) 2004-12-20
UY27365A1 (es) 2003-04-30
GT200200139A (es) 2003-02-13
ZA200309747B (en) 2005-05-27
CN1522152A (zh) 2004-08-18
YU102103A (sh) 2006-05-25
OA12640A (en) 2006-06-15
CZ20033465A3 (cs) 2004-12-15
AP2002002568A0 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
IL159516A0 (en) Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
EP1577410A4 (en) HOT-ROLLED ROLLING WIRE WITH VERY GOOD WIRE-TOOTHING CAPACITY AND AVOIDING HEAT TREATMENT BEFORE WIRE-TOWING
HRP20050192A2 (en) Vaccine for respiratory and reproductive system infections in cattle
EP1383374A4 (en) DEVICE AND METHOD FOR TRAINING ANIMALS
EP1257565A4 (en) DERIVED FROM MUCIN-1 ANTIGENE AND ITS USE IN IMMUNOTHERAPY
AU5695701A (en) Salmonella vaccine materials and methods
EP1450752A4 (en) MULTIVALENT VACCINE COMPOSITIONS CONTAINING STREPTOCOCCUS AND METHODS OF USE
AU2002358036A1 (en) Methods and compositions for use in pet breeding
AU2002346960A1 (en) Methods and compositions for promoting growth and innate immunity in young animals
EP1583557A4 (en) VACCINE COMPOSITIONS AND METHODS
SI1442114T1 (sl) Bakterija, ki povzroča bolezen perutnine, in cepivo izvedeno iz nje
IL163859A0 (en) Multiple and multivalent dna vaccines in ovo
GB2372360B (en) Improvements in and relating to credential transfer methods
AU2003263895A8 (en) Contraceptive methods and formulations
GB0127657D0 (en) Virulence genes and proteins and their use
AU2002360771A8 (en) Recoverable cut-through buffer and method
GB0317376D0 (en) Immunogenic protein and uses thereof
ZA200500166B (en) Methods of treating microbial infections in humans and animals
AU2002211637A1 (en) Probiotic compositions and methods against bacterial infection in livestock animals
EP1471888A4 (en) FORMULATIONS AND TREATMENTS OF ORAL TRIMETHOBENZAMIDE
IL162103A0 (en) Methods of treating bacterial infections in dogs and cats
AUPR042100A0 (en) Vaccines and methods of vaccination
GB0003984D0 (en) Immune response stimulation in man and animals
TW519907U (en) Massaging bar with vibration and hot airflow
GB0008744D0 (en) Hair treatment device and method

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)